KETAMINE HYDROCHLORIDE

KETAMINE HYDROCHLORIDE was reported 5132 times

KETAMINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BIOPSY BLADDER ABNORMAL 11 0.5500
1 CYSTITIS ULCERATIVE 26 0.3881
2 MITOCHONDRIAL DNA MUTATION 33 0.3837
3 URETERAL POLYP 9 0.3333
4 REDUCED BLADDER CAPACITY 28 0.3146
5 DEVICE WIRELESS COMMUNICATION ISSUE 68 0.2625
6 SCHIZENCEPHALY 11 0.2444
7 INSPIRATORY CAPACITY DECREASED 66 0.2383
8 CEREBRAL HAEMORRHAGE FOETAL 11 0.1803
9 DEVICE MAINTENANCE ISSUE 98 0.1667
10 CSF OLIGOCLONAL BAND PRESENT 21 0.1615
11 INFUSION SITE LACERATION 3 0.1500
12 CONTRACTED BLADDER 24 0.1491
13 UNEVALUABLE DEVICE ISSUE 13 0.1461
14 DILATATION INTRAHEPATIC DUCT ACQUIRED 42 0.1438
15 INFUSION SITE INJURY 23 0.1307
16 INTRA-ABDOMINAL PRESSURE INCREASED 19 0.1210
17 INFUSION SITE DRYNESS 6 0.1111
18 MECHANICAL VENTILATION COMPLICATION 15 0.1007
19 INFUSION SITE EROSION 4 0.0976
20 INFUSION SITE STREAKING 8 0.0920
21 INFUSION SITE DISCHARGE 150 0.0855
22 INFUSION SITE SCAB 10 0.0813
23 STERILE PYURIA 5 0.0781
24 INFUSION SITE IRRITATION 100 0.0778
25 INFUSION SITE INDURATION 113 0.0762
26 BLADDER ULCER 3 0.0732
27 INFUSION SITE WARMTH 86 0.0701
28 INFUSION SITE INFLAMMATION 49 0.0694
29 LOWER URINARY TRACT SYMPTOMS 25 0.0691
30 INFUSION SITE HAEMORRHAGE 227 0.0689
31 ADMINISTRATION SITE ODOUR 5 0.0658
32 INFUSION SITE INFECTION 151 0.0649
33 INFUSION SITE NODULE 62 0.0645
34 INFUSION SITE DISCOLOURATION 56 0.0636
35 NEW ONSET REFRACTORY STATUS EPILEPTICUS 7 0.0636
36 INFUSION SITE PAIN 797 0.0618
37 PATIENT DISSATISFACTION WITH DEVICE 15 0.0595
38 INFUSION SITE ERYTHEMA 501 0.0594
39 INFUSION SITE HYPERSENSITIVITY 7 0.0583
40 INFUSION SITE EXFOLIATION 3 0.0577
41 INFUSION SITE SWELLING 347 0.0551
42 DEVICE INFUSION ISSUE 134 0.0540
43 DEVICE TEMPERATURE ISSUE 4 0.0533
44 INFUSION SITE CELLULITIS 27 0.0511
45 BLOOD GASES ABNORMAL 27 0.0501
46 PROPOFOL INFUSION SYNDROME 35 0.0496
47 BURKHOLDERIA TEST POSITIVE 6 0.0484
48 BLADDER NECROSIS 3 0.0469
49 BILIARY TRACT DISORDER 63 0.0455
50 ANAL HYPOAESTHESIA 3 0.0441
51 INFUSION SITE DISCOMFORT 44 0.0424
52 NECROSIS ISCHAEMIC 19 0.0412
53 POSTOPERATIVE DELIRIUM 8 0.0404
54 INFUSION SITE REACTION 116 0.0388
55 PNEUMATOSIS 17 0.0381
56 PLEOCYTOSIS 21 0.0361
57 URETERITIS 10 0.0357
58 INFUSION SITE PRURITUS 109 0.0345
59 OBSTRUCTIVE NEPHROPATHY 4 0.0325
60 INFUSION SITE VESICLES 17 0.0323
61 INFUSION SITE MASS 35 0.0322
62 INFUSION SITE HYPOAESTHESIA 3 0.0316
63 VASCULAR GRAFT OCCLUSION 12 0.0312
64 ADMINISTRATION SITE WOUND 3 0.0303
65 BLADDER NECK OBSTRUCTION 4 0.0292
66 INFUSION SITE RASH 39 0.0284
67 BLADDER HYPERTROPHY 12 0.0271
68 INFUSION SITE SCAR 12 0.0271
69 URETERAL DISORDER 11 0.0268
70 URETERIC STENOSIS 21 0.0262
71 CATHETER SITE DISCOLOURATION 3 0.0246
72 INFUSION SITE ABSCESS 12 0.0238
73 DEVICE ALARM ISSUE 43 0.0237
74 DEVICE POWER SOURCE ISSUE 69 0.0236
75 MEDICAL DEVICE SITE ERYTHEMA 3 0.0234
76 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 13 0.0232
77 INFUSION SITE BRUISING 49 0.0227
78 UROGENITAL FISTULA 5 0.0211
79 BILIARY DILATATION 31 0.0211
80 HYDROURETER 8 0.0211
81 CATHETER SITE IRRITATION 7 0.0210
82 CATHETER SITE INDURATION 4 0.0207
83 PRODUCT USED FOR UNKNOWN INDICATION 26 0.0207
84 AIRWAY COMPLICATION OF ANAESTHESIA 5 0.0190
85 RENAL PAPILLARY NECROSIS 4 0.0186
86 URGE INCONTINENCE 16 0.0184
87 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 18 0.0179
88 PERFORATION 14 0.0174
89 CHOLANGITIS SCLEROSING 35 0.0170
90 CYSTITIS INTERSTITIAL 27 0.0168
91 ENVIRONMENTAL EXPOSURE 4 0.0167
92 DEVICE CONNECTION ISSUE 34 0.0161
93 GENE MUTATION 31 0.0156
94 ANAEMIA FOLATE DEFICIENCY 3 0.0155
95 MYOCARDIAL DEPRESSION 4 0.0155
96 PYURIA 15 0.0152
97 HYDRONEPHROSIS 113 0.0151
98 PROCEDURAL INTESTINAL PERFORATION 4 0.0150
99 PURULENT DISCHARGE 64 0.0150
100 ANTITHROMBIN III DECREASED 4 0.0147
101 DEVICE ELECTRICAL FINDING 10 0.0141
102 URETERIC OBSTRUCTION 18 0.0132
103 INFUSION SITE OEDEMA 11 0.0132
104 NEUROGENIC BOWEL 3 0.0126
105 CATHETER SITE BRUISE 4 0.0121
106 DEVICE ALLERGY 3 0.0120
107 INFUSION SITE URTICARIA 8 0.0119
108 CHEMICAL SUBMISSION 3 0.0119
109 DIET NONCOMPLIANCE 4 0.0109
110 PRODUCT MONITORING ERROR 15 0.0104
111 URINARY TRACT DISORDER 45 0.0100
112 DISSOCIATIVE DISORDER 7 0.0097
113 ACCIDENTAL DEATH 18 0.0097
114 CATHETER SITE SWELLING 9 0.0096
115 INJECTION SITE THROMBOSIS 3 0.0091
116 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 6 0.0090
117 SUBSTANCE USE 14 0.0090
118 BODY TINEA 5 0.0089
119 SUBSTANCE DEPENDENCE 6 0.0089
120 CATHETER SITE DISCHARGE 10 0.0089
121 SEDATION 232 0.0088
122 DERMATITIS CONTACT 97 0.0085
123 METAPLASIA 4 0.0085
124 DELAYED RECOVERY FROM ANAESTHESIA 8 0.0084
125 CATHETER SITE ERYTHEMA 18 0.0084
126 INFUSION SITE HAEMATOMA 4 0.0084
127 DEVICE LOOSENING 7 0.0081
128 MULTIPLE-DRUG RESISTANCE 25 0.0081
129 DEVICE OCCLUSION 113 0.0080
130 DEVICE USE CONFUSION 4 0.0076
131 OXYGEN CONSUMPTION INCREASED 18 0.0075
132 VENOOCCLUSIVE LIVER DISEASE 37 0.0075
133 HAEMOGLOBIN INCREASED 34 0.0074
134 DEVICE COLOUR ISSUE 3 0.0074
135 CYTOKINE STORM 5 0.0073
136 MEDICAL DEVICE SITE PAIN 4 0.0071
137 DEVICE FAILURE 105 0.0069
138 HYPERVOLAEMIA 34 0.0069
139 DEVICE PLACEMENT ISSUE 24 0.0067
140 BILIARY SEPSIS 3 0.0065
141 ANTINUCLEAR ANTIBODY POSITIVE 21 0.0065
142 DRUG TOLERANCE INCREASED 5 0.0064
143 PRIMARY BILIARY CHOLANGITIS 3 0.0064
144 ANAPHYLACTOID SHOCK 3 0.0064
145 LARYNGOSPASM 17 0.0063
146 NIGHTMARE 217 0.0063
147 PERSONAL RELATIONSHIP ISSUE 4 0.0060
148 DEVICE PHYSICAL PROPERTY ISSUE 44 0.0057
149 HYPOPERFUSION 6 0.0057
150 PRODUCT LEAKAGE 32 0.0057
151 TRYPTASE INCREASED 4 0.0056
152 PARTIAL SEIZURES 29 0.0055
153 INTESTINAL ISCHAEMIA 30 0.0054
154 DIABETES INSIPIDUS 13 0.0054
155 CATHETER SITE PAIN 14 0.0054
156 SPONTANEOUS HAEMATOMA 4 0.0054
157 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 20 0.0052
158 CYSTITIS NONINFECTIVE 7 0.0052
159 CATHETER SITE HAEMORRHAGE 13 0.0052
160 HAEMOTHORAX 15 0.0052
161 PRODUCT ADMINISTRATION INTERRUPTED 40 0.0051
162 CHOLESTATIC LIVER INJURY 11 0.0049
163 BLOOD LACTIC ACID INCREASED 26 0.0049
164 BLADDER DISORDER 49 0.0049
165 BLADDER DYSFUNCTION 5 0.0049
166 HYPERTONIC BLADDER 14 0.0048
167 HEPATOBILIARY DISEASE 3 0.0048
168 VENOOCCLUSIVE DISEASE 12 0.0048
169 ABDOMINAL COMPARTMENT SYNDROME 3 0.0047
170 DEVICE KINK 17 0.0047
171 DRUG TITRATION ERROR 12 0.0046
172 TRAUMATIC INTRACRANIAL HAEMORRHAGE 4 0.0044
173 NEPHROLITHIASIS 194 0.0042
174 URINARY TRACT OBSTRUCTION 10 0.0042
175 BLOOD PH DECREASED 7 0.0041
176 INCORRECT DRUG ADMINISTRATION RATE 17 0.0040
177 UNINTENTIONAL MEDICAL DEVICE REMOVAL 46 0.0040
178 DISTRIBUTIVE SHOCK 9 0.0040
179 VASCULAR DEVICE INFECTION 18 0.0040
180 ANAPHYLACTIC SHOCK 102 0.0040
181 DIZZINESS EXERTIONAL 3 0.0039
182 HYPERTROPHIC CARDIOMYOPATHY 6 0.0039
183 BRUGADA SYNDROME 4 0.0039
184 INHIBITORY DRUG INTERACTION 6 0.0038
185 DRUG ABUSE 315 0.0038
186 ENCEPHALITIS 26 0.0038
187 LIVER ABSCESS 12 0.0037
188 METABOLIC SYNDROME 6 0.0036
189 STATUS EPILEPTICUS 41 0.0036
190 RIGHT VENTRICULAR DYSFUNCTION 4 0.0036
191 MYOCARDIAL FIBROSIS 3 0.0036
192 CATHETER SITE PRURITUS 3 0.0034
193 HYPOVOLAEMIA 20 0.0034
194 HYPERTHERMIA MALIGNANT 5 0.0034
195 DEVICE INFORMATION OUTPUT ISSUE 26 0.0033
196 THERAPY NON-RESPONDER 150 0.0033
197 ANAESTHETIC COMPLICATION NEUROLOGICAL 3 0.0033
198 INTESTINAL INFARCTION 3 0.0033
199 PAIN IN JAW 93 0.0033
200 LEFT VENTRICULAR HYPERTROPHY 14 0.0033
201 DEVICE DISLOCATION 137 0.0031
202 THERAPY PARTIAL RESPONDER 49 0.0031
203 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
204 INCREASED BRONCHIAL SECRETION 8 0.0031
205 DISCOLOURED VOMIT 3 0.0031
206 PULMONARY ARTERIAL HYPERTENSION 43 0.0030
207 RENAL ARTERY STENOSIS 4 0.0029
208 DRUG TOLERANCE DECREASED 8 0.0028
209 HYPERKINESIA 6 0.0028
210 CYSTITIS 89 0.0028
211 PORPHYRIA ACUTE 4 0.0028
212 SEDATION COMPLICATION 7 0.0027
213 INFECTION SUSCEPTIBILITY INCREASED 6 0.0027
214 APNOEA 21 0.0027
215 RESPIRATORY DEPRESSION 33 0.0027
216 ANGIOPATHY 15 0.0027
217 STEROID DIABETES 4 0.0027
218 HYPERCAPNIA 8 0.0027
219 ADMINISTRATION SITE PAIN 3 0.0026
220 DRUG ABUSER 16 0.0026
221 NEPHROGENIC DIABETES INSIPIDUS 3 0.0026
222 DEVICE USE ERROR 90 0.0026
223 PROCALCITONIN INCREASED 3 0.0026
224 BILE DUCT STENOSIS 3 0.0025
225 BLOOD IMMUNOGLOBULIN E INCREASED 6 0.0025
226 DIZZINESS POSTURAL 24 0.0025
227 SUSPECTED OFF LABEL USE 11 0.0024
228 PULMONARY HYPERTENSION 50 0.0024
229 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
230 SHOCK 55 0.0024
231 BRONCHOSPASM 34 0.0024
232 SHOCK HAEMORRHAGIC 19 0.0023
233 LYMPHOCYTOSIS 5 0.0023
234 HYDROCEPHALUS 12 0.0022
235 CARBON DIOXIDE INCREASED 3 0.0022
236 SEASONAL ALLERGY 31 0.0022
237 DYSPHORIA 11 0.0022
238 PERIPHERAL MOTOR NEUROPATHY 3 0.0021
239 FINE MOTOR SKILL DYSFUNCTION 6 0.0021
240 HEPATOTOXICITY 46 0.0021
241 DEVICE LEAKAGE 88 0.0020
242 DRUG SCREEN POSITIVE 16 0.0020
243 DEVICE RELATED SEPSIS 4 0.0020
244 MICTURITION URGENCY 22 0.0019
245 SUSPECTED SUICIDE 9 0.0019
246 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
247 ANAL INCONTINENCE 17 0.0019
248 HYPERPHOSPHATAEMIA 4 0.0019
249 DEREALISATION 4 0.0019
250 HYPOGLYCAEMIA NEONATAL 3 0.0019
251 BLOOD SODIUM INCREASED 5 0.0019
252 HYPERHIDROSIS 238 0.0018
253 SUBSTANCE ABUSE 15 0.0018
254 HYPOVENTILATION 6 0.0018
255 HYPERAESTHESIA 15 0.0018
256 OXYGEN SATURATION DECREASED 102 0.0018
257 IGA NEPHROPATHY 3 0.0018
258 BRAIN INJURY 18 0.0018
259 OXYGEN SATURATION ABNORMAL 5 0.0018
260 HYPOXIA 62 0.0018
261 METABOLIC ACIDOSIS 56 0.0017
262 FUNCTIONAL GASTROINTESTINAL DISORDER 6 0.0017
263 KIDNEY FIBROSIS 3 0.0017
264 METHAEMOGLOBINAEMIA 4 0.0017
265 RIGHT VENTRICULAR FAILURE 12 0.0017
266 ABORTION INDUCED 16 0.0017
267 JAUNDICE CHOLESTATIC 6 0.0017
268 DEVICE ADHESION ISSUE 26 0.0017
269 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 92 0.0017
270 URINARY HESITATION 4 0.0017
271 DYSPNOEA EXERTIONAL 63 0.0017
272 PNEUMOMEDIASTINUM 3 0.0017
273 LIVER FUNCTION TEST ABNORMAL 48 0.0016
274 ESSENTIAL HYPERTENSION 3 0.0016
275 HAEMATOLOGICAL INFECTION 4 0.0016
276 HAEMATURIA 56 0.0016
277 HOMICIDE 3 0.0016
278 BRAIN DEATH 5 0.0016
279 RESPIRATORY RATE DECREASED 5 0.0016
280 HUMAN HERPESVIRUS 6 INFECTION 3 0.0016
281 EMPHYSEMA 16 0.0016
282 GENERALISED ERYTHEMA 9 0.0016
283 BONE MARROW TRANSPLANT 3 0.0016
284 DRUG TOLERANCE 8 0.0016
285 PNEUMOTHORAX 25 0.0016
286 CANCER PAIN 4 0.0016
287 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
288 STRESS CARDIOMYOPATHY 9 0.0015
289 EARLY SATIETY 3 0.0015
290 DEVICE ISSUE 137 0.0015
291 DELIRIUM 53 0.0015
292 HYPERAEMIA 3 0.0015
293 INJECTION SITE INFECTION 5 0.0015
294 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
295 ARTERIOSPASM CORONARY 6 0.0015
296 SENSITIVE SKIN 11 0.0015
297 ANAESTHETIC COMPLICATION 4 0.0015
298 POOR QUALITY SLEEP 32 0.0015
299 BRADYPNOEA 4 0.0015
300 CARDIOMEGALY 18 0.0015
301 HYPERTRANSAMINASAEMIA 10 0.0014
302 ENDOTRACHEAL INTUBATION 4 0.0014
303 BLOOD CREATINE PHOSPHOKINASE INCREASED 40 0.0014
304 DYSPNOEA AT REST 4 0.0014
305 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
306 LIVER TRANSPLANT 5 0.0014
307 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
308 PARONYCHIA 6 0.0014
309 TRISMUS 7 0.0014
310 IMPULSIVE BEHAVIOUR 5 0.0013
311 BLOOD LOSS ANAEMIA 3 0.0013
312 CATHETER SITE INFECTION 5 0.0013
313 HAEMODYNAMIC INSTABILITY 10 0.0013
314 DISSOCIATION 10 0.0013
315 CHOLESTASIS 25 0.0013
316 ACUTE RESPIRATORY FAILURE 25 0.0013
317 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
318 RENAL FUNCTION TEST ABNORMAL 6 0.0013
319 INFUSION SITE EXTRAVASATION 8 0.0013
320 BLOOD BLISTER 4 0.0013
321 PULMONARY HAEMORRHAGE 10 0.0013
322 WOUND INFECTION 14 0.0013
323 IMPAIRED QUALITY OF LIFE 18 0.0013
324 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
325 RESPIRATORY FAILURE 91 0.0012
326 CYSTITIS HAEMORRHAGIC 5 0.0012
327 FACE OEDEMA 20 0.0012
328 ACIDOSIS 9 0.0012
329 DRUG TOXICITY 16 0.0012
330 ABDOMINAL INFECTION 3 0.0012
331 CARDIO-RESPIRATORY ARREST 49 0.0012
332 PROTHROMBIN TIME PROLONGED 7 0.0012
333 LEFT VENTRICULAR FAILURE 4 0.0012
334 MANIA 19 0.0012
335 DEVICE MALFUNCTION 81 0.0012
336 COMPARTMENT SYNDROME 3 0.0011
337 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
338 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
339 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
340 FLUID RETENTION 58 0.0011
341 TYPE I HYPERSENSITIVITY 4 0.0011
342 ADVERSE REACTION 15 0.0011
343 CHOLANGITIS 7 0.0011
344 ABSCESS 18 0.0011
345 MIOSIS 9 0.0011
346 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
347 INJECTION SITE DISCHARGE 6 0.0011
348 EAR CONGESTION 3 0.0011
349 VENTRICULAR ARRHYTHMIA 4 0.0011
350 MYOCLONUS 13 0.0011
351 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0011
352 ELECTROCARDIOGRAM QT PROLONGED 39 0.0011
353 LEUKOENCEPHALOPATHY 4 0.0011
354 INTESTINAL PERFORATION 12 0.0011
355 IMMUNE THROMBOCYTOPENIC PURPURA 3 0.0011
356 SKIN ABRASION 5 0.0011
357 CIRCULATORY COLLAPSE 18 0.0011
358 HYPOTENSION 212 0.0011
359 PNEUMATOSIS INTESTINALIS 3 0.0011
360 POST-TRAUMATIC STRESS DISORDER 7 0.0010
361 HALLUCINATION, VISUAL 22 0.0010
362 BILIARY COLIC 3 0.0010
363 BRAIN FOG 16 0.0010
364 RESPIRATORY ACIDOSIS 4 0.0010
365 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
366 ANAPHYLACTIC REACTION 56 0.0010
367 SALIVARY HYPERSECRETION 10 0.0010
368 DIABETIC FOOT 3 0.0010
369 FIBROSIS 3 0.0010
370 LARYNGEAL OEDEMA 6 0.0010
371 SELF-MEDICATION 4 0.0010
372 SUICIDAL BEHAVIOUR 4 0.0010
373 MAJOR DEPRESSION 7 0.0010
374 CATATONIA 5 0.0010
375 DEVICE DIFFICULT TO USE 63 0.0010
376 ARRHYTHMIA 45 0.0009
377 NEURALGIA 23 0.0009
378 BLADDER PAIN 3 0.0009
379 NYSTAGMUS 5 0.0009
380 ABNORMAL SENSATION IN EYE 4 0.0009
381 DYSURIA 34 0.0009
382 MONOPLEGIA 4 0.0009
383 CARDIOGENIC SHOCK 13 0.0009
384 HYPOALBUMINAEMIA 7 0.0009
385 EPISTAXIS 67 0.0009
386 PULMONARY OEDEMA 40 0.0009
387 IMPAIRED WORK ABILITY 19 0.0009
388 POSTOPERATIVE WOUND INFECTION 6 0.0009
389 POLLAKIURIA 37 0.0009
390 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
391 ILEUS 11 0.0009
392 CARBOHYDRATE ANTIGEN 125 INCREASED 3 0.0009
393 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
394 HYPERTONIA 5 0.0009
395 CARDIAC ARREST 72 0.0009
396 RESPIRATION ABNORMAL 6 0.0009
397 LOCALISED OEDEMA 4 0.0009
398 ASPHYXIA 7 0.0009
399 NEUROTOXICITY 15 0.0009
400 TACHYCARDIA 76 0.0009
401 PRODUCT USE IN UNAPPROVED INDICATION 211 0.0009
402 PULSE ABSENT 4 0.0008
403 PERICARDIAL EFFUSION 19 0.0008
404 BLOOD PHOSPHORUS DECREASED 3 0.0008
405 PARADOXICAL DRUG REACTION 3 0.0008
406 VENTRICULAR FIBRILLATION 9 0.0008
407 PYELONEPHRITIS 7 0.0008
408 PRE-EXISTING CONDITION IMPROVED 5 0.0008
409 RESPIRATORY ARREST 22 0.0008
410 OEDEMA 43 0.0008
411 VENTRICULAR TACHYCARDIA 13 0.0008
412 EUPHORIC MOOD 8 0.0008
413 URINARY INCONTINENCE 23 0.0008
414 UNRESPONSIVE TO STIMULI 20 0.0008
415 INCOHERENT 5 0.0008
416 CERVIX CARCINOMA 3 0.0008
417 APLASTIC ANAEMIA 4 0.0008
418 WEIGHT FLUCTUATION 8 0.0008
419 BACTERAEMIA 9 0.0008
420 DEVICE USE ISSUE 13 0.0007
421 WRONG PRODUCT ADMINISTERED 5 0.0007
422 HOMICIDAL IDEATION 3 0.0007
423 ERYTHEMA OF EYELID 4 0.0007
424 POLYURIA 6 0.0007
425 JOINT EFFUSION 5 0.0007
426 PNEUMONIA ASPIRATION 18 0.0007
427 GASTROENTERITIS VIRAL 13 0.0007
428 BRADYCARDIA 38 0.0007
429 POISONING 9 0.0007
430 BLOOD TEST ABNORMAL 10 0.0007
431 BLOOD BILIRUBIN INCREASED 19 0.0007
432 EXERCISE TOLERANCE DECREASED 4 0.0007
433 RESPIRATORY TRACT CONGESTION 11 0.0007
434 HEPATIC CIRRHOSIS 13 0.0007
435 NAUSEA 545 0.0007
436 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
437 MOUTH HAEMORRHAGE 5 0.0007
438 TOXICITY TO VARIOUS AGENTS 114 0.0007
439 STEVENS-JOHNSON SYNDROME 15 0.0007
440 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
441 ALANINE AMINOTRANSFERASE INCREASED 41 0.0007
442 HEAVY MENSTRUAL BLEEDING 6 0.0007
443 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
444 HEPATITIS CHOLESTATIC 4 0.0007
445 ABDOMINAL DISTENSION 69 0.0007
446 URINARY RETENTION 22 0.0007
447 FOETAL GROWTH RESTRICTION 4 0.0007
448 BLOOD UREA INCREASED 11 0.0007
449 HYPERKALAEMIA 23 0.0007
450 ILLNESS 67 0.0006
451 GRAND MAL CONVULSION 6 0.0006
452 DELUSION 10 0.0006
453 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
454 SWELLING OF EYELID 4 0.0006
455 CARDIAC TAMPONADE 3 0.0006
456 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
457 EOSINOPHILIA 11 0.0006
458 HYPOVOLAEMIC SHOCK 3 0.0006
459 RHABDOMYOLYSIS 26 0.0006
460 HAEMOGLOBIN ABNORMAL 4 0.0006
461 OFF LABEL USE 539 0.0006
462 MENTAL STATUS CHANGES 17 0.0006
463 PRODUCT PREPARATION ISSUE 4 0.0006
464 RESTLESS LEGS SYNDROME 11 0.0006
465 FLUSHING 61 0.0006
466 HALLUCINATION 45 0.0006
467 DRUG USE DISORDER 5 0.0006
468 COVID-19 PNEUMONIA 7 0.0006
469 HEPATIC FUNCTION ABNORMAL 22 0.0006
470 BLOOD PRESSURE DECREASED 39 0.0006
471 MIGRAINE 56 0.0006
472 HYPERLIPIDAEMIA 7 0.0006
473 ENDOCARDITIS 3 0.0006
474 NOCTURIA 7 0.0006
475 LARGE INTESTINE PERFORATION 4 0.0006
476 STAPHYLOCOCCAL INFECTION 19 0.0006
477 SCHIZOPHRENIA 7 0.0006
478 AUTOIMMUNE HEPATITIS 4 0.0006
479 CYANOSIS 9 0.0006
480 FOLLICULITIS 6 0.0006
481 PRODUCT COMMUNICATION ISSUE 5 0.0006
482 HALLUCINATION, AUDITORY 9 0.0006
483 PURPURA 5 0.0006
484 HEPATOCELLULAR INJURY 8 0.0006
485 BRAIN OEDEMA 7 0.0006
486 DYSPNOEA 313 0.0006
487 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
488 FAECES SOFT 4 0.0005
489 FAECALOMA 3 0.0005
490 HEADACHE 342 0.0005
491 DEAFNESS UNILATERAL 3 0.0005
492 ASCITES 16 0.0005
493 UROSEPSIS 5 0.0005
494 NECROSIS 3 0.0005
495 HAEMOPTYSIS 15 0.0005
496 APPENDICITIS 5 0.0005
497 ACUTE PULMONARY OEDEMA 3 0.0005
498 PERIORBITAL SWELLING 3 0.0005
499 DRUG INTERACTION 84 0.0005
500 HYPERTHERMIA 4 0.0005
501 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
502 SEROTONIN SYNDROME 10 0.0005
503 ACCIDENTAL OVERDOSE 19 0.0005
504 HYPERVENTILATION 3 0.0005
505 SINUS BRADYCARDIA 5 0.0005
506 METABOLIC DISORDER 3 0.0005
507 RETCHING 11 0.0005
508 VASCULITIS 6 0.0005
509 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
510 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
511 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
512 TORSADE DE POINTES 4 0.0005
513 RESPIRATORY DISTRESS 14 0.0005
514 SEPTIC SHOCK 22 0.0005
515 NASAL DISCOMFORT 4 0.0005
516 GINGIVAL PAIN 4 0.0005
517 MUSCLE RIGIDITY 6 0.0005
518 NASAL CONGESTION 29 0.0005
519 PLEURAL EFFUSION 30 0.0005
520 DRUG LEVEL DECREASED 5 0.0005
521 DIARRHOEA 317 0.0005
522 DECUBITUS ULCER 4 0.0005
523 LIVER INJURY 12 0.0005
524 DRUG DIVERSION 3 0.0005
525 SEPSIS 54 0.0005
526 OLIGURIA 3 0.0005
527 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
528 NERVOUS SYSTEM DISORDER 15 0.0005
529 SECRETION DISCHARGE 6 0.0005
530 VOMITING 225 0.0005
531 PSYCHOTIC DISORDER 14 0.0005
532 INJECTION SITE IRRITATION 6 0.0005
533 HEPATIC CYTOLYSIS 6 0.0005
534 OEDEMA PERIPHERAL 57 0.0005
535 INFLUENZA 52 0.0005
536 DECREASED ACTIVITY 5 0.0005
537 HEPATITIS ACUTE 3 0.0005
538 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
539 URINE OUTPUT DECREASED 4 0.0005
540 ACUTE KIDNEY INJURY 70 0.0005
541 HYPOGAMMAGLOBULINAEMIA 3 0.0005
542 ASPIRATION 5 0.0005
543 DISORIENTATION 18 0.0005
544 HYPERSOMNIA 13 0.0005
545 MUSCULOSKELETAL CHEST PAIN 7 0.0005
546 LETHARGY 26 0.0005
547 LIVER DISORDER 20 0.0005
548 AGITATION 33 0.0004
549 MENINGITIS 3 0.0004
550 WRONG DRUG ADMINISTERED 4 0.0004
551 CYTOKINE RELEASE SYNDROME 9 0.0004
552 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
553 PAIN IN EXTREMITY 132 0.0004
554 ENCEPHALOPATHY 11 0.0004
555 HEART RATE INCREASED 44 0.0004
556 SINUS CONGESTION 6 0.0004
557 COMPLETED SUICIDE 37 0.0004
558 PALLOR 12 0.0004
559 DECREASED APPETITE 102 0.0004
560 EYE MOVEMENT DISORDER 3 0.0004
561 CATARACT 26 0.0004
562 LYMPHOEDEMA 3 0.0004
563 BLOOD POTASSIUM DECREASED 13 0.0004
564 EYELID OEDEMA 5 0.0004
565 HEPATITIS 11 0.0004
566 CAESAREAN SECTION 5 0.0004
567 COGNITIVE DISORDER 20 0.0004
568 DRUG INEFFECTIVE 564 0.0004
569 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
570 SPINAL PAIN 5 0.0004
571 SKIN REACTION 6 0.0004
572 WEIGHT DECREASED 118 0.0004
573 PERIPHERAL SWELLING 65 0.0004
574 POISONING DELIBERATE 4 0.0004
575 LOSS OF CONSCIOUSNESS 54 0.0004
576 SLEEP APNOEA SYNDROME 8 0.0004
577 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
578 PALPITATIONS 49 0.0004
579 MENTAL IMPAIRMENT 10 0.0004
580 NEEDLE ISSUE 12 0.0004
581 NECK PAIN 23 0.0004
582 HEAD INJURY 13 0.0004
583 VITAMIN D DEFICIENCY 4 0.0004
584 HAEMORRHOIDS 8 0.0004
585 HEPATOMEGALY 4 0.0004
586 CARDIOMYOPATHY 6 0.0004
587 CEREBRAL DISORDER 3 0.0004
588 RASH MACULO-PAPULAR 9 0.0004
589 GENERALISED OEDEMA 5 0.0004
590 COLON CANCER 6 0.0004
591 SOMNOLENCE 81 0.0004
592 HYPOTONIA 4 0.0004
593 PAROSMIA 3 0.0004
594 HEAD DISCOMFORT 7 0.0004
595 FEEDING DISORDER 8 0.0004
596 PRODUCT ADHESION ISSUE 14 0.0004
597 CONDITION AGGRAVATED 119 0.0004
598 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
599 FLATULENCE 22 0.0004
600 HYPERBILIRUBINAEMIA 4 0.0004
601 EXPOSURE VIA SKIN CONTACT 10 0.0004
602 END STAGE RENAL DISEASE 7 0.0004
603 DRUG-INDUCED LIVER INJURY 12 0.0004
604 PRODUCT SUBSTITUTION ISSUE 22 0.0004
605 AFFECTIVE DISORDER 3 0.0004
606 RENAL IMPAIRMENT 32 0.0004
607 BONE PAIN 22 0.0004
608 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
609 BACK PAIN 87 0.0004
610 FRUSTRATION TOLERANCE DECREASED 3 0.0004
611 DIZZINESS 185 0.0004
612 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
613 SKIN LACERATION 4 0.0004
614 RESPIRATORY DISORDER 11 0.0004
615 CHEST PAIN 68 0.0004
616 GINGIVAL BLEEDING 5 0.0004
617 ABNORMAL FAECES 3 0.0004
618 HEPATIC FAILURE 11 0.0004
619 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
620 DYSTONIA 7 0.0004
621 EAR PAIN 7 0.0004
622 TRANSAMINASES INCREASED 8 0.0004
623 CONFUSIONAL STATE 58 0.0004
624 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
625 HAEMODIALYSIS 3 0.0004
626 GASTROINTESTINAL DISORDER 32 0.0004
627 CARPAL TUNNEL SYNDROME 5 0.0004
628 CANDIDA INFECTION 6 0.0004
629 HAEMATEMESIS 9 0.0004
630 FEELING ABNORMAL 85 0.0004
631 URTICARIA 59 0.0004
632 SINUS TACHYCARDIA 5 0.0004
633 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
634 SUICIDAL IDEATION 32 0.0003
635 PARANOIA 6 0.0003
636 FULL BLOOD COUNT DECREASED 7 0.0003
637 HAEMORRHAGE 36 0.0003
638 POST PROCEDURAL HAEMORRHAGE 4 0.0003
639 INTENTIONAL PRODUCT MISUSE 30 0.0003
640 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
641 PANCREATITIS 18 0.0003
642 LYMPHOCYTE COUNT DECREASED 6 0.0003
643 CARDIAC FAILURE 27 0.0003
644 GALLBLADDER DISORDER 6 0.0003
645 CHOLECYSTITIS 4 0.0003
646 PAIN 206 0.0003
647 ACCIDENT 4 0.0003
648 MYOSITIS 3 0.0003
649 BLOOD PRESSURE FLUCTUATION 8 0.0003
650 FEBRILE NEUTROPENIA 22 0.0003
651 DRUG INTOLERANCE 32 0.0003
652 VIRAL INFECTION 11 0.0003
653 SUICIDE ATTEMPT 20 0.0003
654 PRESYNCOPE 8 0.0003
655 NERVE COMPRESSION 3 0.0003
656 IRON DEFICIENCY ANAEMIA 3 0.0003
657 DEVICE RELATED INFECTION 5 0.0003
658 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
659 PRODUCT USE ISSUE 61 0.0003
660 PHARYNGITIS 4 0.0003
661 ERYTHEMA MULTIFORME 3 0.0003
662 HYPONATRAEMIA 18 0.0003
663 NEUTROPHIL COUNT DECREASED 13 0.0003
664 CELLULITIS 16 0.0003
665 HYPOCALCAEMIA 6 0.0003
666 MUSCLE ATROPHY 4 0.0003
667 COMA 15 0.0003
668 CHEST DISCOMFORT 32 0.0003
669 POST PROCEDURAL COMPLICATION 6 0.0003
670 MYDRIASIS 4 0.0003
671 AFFECT LABILITY 3 0.0003
672 PANCREATITIS ACUTE 7 0.0003
673 OVERDOSE 67 0.0003
674 ATELECTASIS 3 0.0003
675 ABDOMINAL PAIN 72 0.0003
676 MUSCLE TIGHTNESS 5 0.0003
677 AUTOIMMUNE DISORDER 3 0.0003
678 CHOLELITHIASIS 10 0.0003
679 DYSPEPSIA 30 0.0003
680 FATIGUE 237 0.0003
681 LIGAMENT SPRAIN 3 0.0003
682 SINUS DISORDER 6 0.0003
683 PANIC ATTACK 11 0.0003
684 RESTLESSNESS 11 0.0003
685 PLATELET COUNT DECREASED 32 0.0003
686 COAGULOPATHY 5 0.0003
687 INJURY 21 0.0003
688 DRUG DEPENDENCE 48 0.0003
689 COUGH 83 0.0003
690 ANXIETY 84 0.0003
691 LIMB INJURY 8 0.0003
692 MOTOR DYSFUNCTION 3 0.0003
693 TACHYPNOEA 4 0.0003
694 IMPAIRED GASTRIC EMPTYING 4 0.0003
695 AKATHISIA 4 0.0003
696 EAR DISCOMFORT 3 0.0003
697 DEVICE DELIVERY SYSTEM ISSUE 8 0.0003
698 LIMB DISCOMFORT 9 0.0003
699 SYNCOPE 29 0.0003
700 PROCEDURAL PAIN 8 0.0003
701 PETECHIAE 3 0.0003
702 LUNG DISORDER 14 0.0003
703 FULL BLOOD COUNT ABNORMAL 3 0.0003
704 MYALGIA 48 0.0003
705 DRUG ERUPTION 5 0.0003
706 HYPOKALAEMIA 13 0.0003
707 PARALYSIS 4 0.0003
708 RHINORRHOEA 18 0.0003
709 HERPES ZOSTER 16 0.0003
710 FEELING HOT 17 0.0003
711 BLOOD CREATININE INCREASED 18 0.0003
712 CRYING 10 0.0003
713 APATHY 4 0.0003
714 TREATMENT NONCOMPLIANCE 15 0.0003
715 HYPOPHAGIA 7 0.0003
716 COVID-19 48 0.0003
717 ERYTHEMA 56 0.0003
718 EXTRA DOSE ADMINISTERED 11 0.0003
719 DEVICE BREAKAGE 11 0.0003
720 INSOMNIA 72 0.0003
721 SKIN DISORDER 9 0.0003
722 NERVE INJURY 3 0.0003
723 HYPERSENSITIVITY 50 0.0003
724 AGRANULOCYTOSIS 5 0.0003
725 BLOOD PRESSURE INCREASED 41 0.0003
726 NERVOUSNESS 14 0.0003
727 SWELLING 25 0.0003
728 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
729 DEPRESSED MOOD 14 0.0003
730 WEIGHT INCREASED 59 0.0003
731 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
732 ABDOMINAL PAIN UPPER 54 0.0003
733 EPILEPSY 8 0.0003
734 CONSTIPATION 57 0.0003
735 NASOPHARYNGITIS 48 0.0003
736 PYREXIA 90 0.0003
737 THYROID DISORDER 4 0.0003
738 ERUCTATION 5 0.0003
739 EXPOSURE DURING PREGNANCY 16 0.0003
740 RASH MACULAR 9 0.0003
741 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 12 0.0003
742 ORAL HERPES 5 0.0003
743 RECTAL HAEMORRHAGE 11 0.0003
744 CHILLS 30 0.0003
745 SKIN LESION 7 0.0003
746 PRODUCT USE COMPLAINT 4 0.0003
747 PNEUMONIA 82 0.0003
748 ATAXIA 3 0.0003
749 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
750 PRODUCTIVE COUGH 12 0.0003
751 OBESITY 4 0.0003
752 MALAISE 110 0.0003
753 PANCYTOPENIA 14 0.0003
754 TARDIVE DYSKINESIA 7 0.0002
755 LOCALISED INFECTION 6 0.0002
756 C-REACTIVE PROTEIN INCREASED 9 0.0002
757 ADRENAL INSUFFICIENCY 3 0.0002
758 FIBROMYALGIA 6 0.0002
759 TASTE DISORDER 5 0.0002
760 NO THERAPEUTIC RESPONSE 3 0.0002
761 INFLUENZA LIKE ILLNESS 20 0.0002
762 HYPERCALCAEMIA 3 0.0002
763 ASTHENIA 91 0.0002
764 TREATMENT FAILURE 20 0.0002
765 TREMOR 40 0.0002
766 EXPIRED PRODUCT ADMINISTERED 8 0.0002
767 FUNGAL INFECTION 8 0.0002
768 ROAD TRAFFIC ACCIDENT 10 0.0002
769 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
770 RENAL FAILURE ACUTE 10 0.0002
771 JOINT INJURY 5 0.0002
772 SEIZURE 27 0.0002
773 IRRITABLE BOWEL SYNDROME 5 0.0002
774 LIVER FUNCTION TEST INCREASED 5 0.0002
775 ABDOMINAL DISCOMFORT 39 0.0002
776 HYPOACUSIS 10 0.0002
777 SKIN ULCER 6 0.0002
778 MULTI-ORGAN FAILURE 4 0.0002
779 PRODUCT DISPENSING ERROR 5 0.0002
780 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
781 GASTRITIS 6 0.0002
782 INFECTION 33 0.0002
783 ABNORMAL BEHAVIOUR 9 0.0002
784 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
785 FEMUR FRACTURE 7 0.0002
786 JAUNDICE 6 0.0002
787 SNEEZING 5 0.0002
788 GOUT 4 0.0002
789 RASH 97 0.0002
790 THROAT TIGHTNESS 6 0.0002
791 DYSKINESIA 9 0.0002
792 LEUKOCYTOSIS 4 0.0002
793 ACUTE HEPATIC FAILURE 3 0.0002
794 PERIPHERAL COLDNESS 3 0.0002
795 AMNESIA 14 0.0002
796 HEPATIC STEATOSIS 4 0.0002
797 BACTERIAL INFECTION 4 0.0002
798 WITHDRAWAL SYNDROME 9 0.0002
799 CARDIAC DISORDER 20 0.0002
800 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
801 FALL 71 0.0002
802 BLOOD SODIUM DECREASED 4 0.0002
803 BLOOD URINE PRESENT 4 0.0002
804 PRODUCT PRESCRIBING ERROR 5 0.0002
805 FEELING JITTERY 4 0.0002
806 CONTUSION 20 0.0002
807 HYPERTENSION 44 0.0002
808 HYPOAESTHESIA 31 0.0002
809 PRESCRIBED OVERDOSE 4 0.0002
810 HYPOKINESIA 3 0.0002
811 SURGERY 12 0.0002
812 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
813 INCORRECT DOSE ADMINISTERED 46 0.0002
814 IMMUNODEFICIENCY 3 0.0002
815 BLOOD PRESSURE ABNORMAL 4 0.0002
816 AGGRESSION 10 0.0002
817 LACRIMATION INCREASED 6 0.0002
818 TINNITUS 9 0.0002
819 DRUG RESISTANCE 5 0.0002
820 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
821 DRUG WITHDRAWAL SYNDROME 17 0.0002
822 MUSCULAR WEAKNESS 22 0.0002
823 URINARY TRACT INFECTION 33 0.0002
824 RENAL DISORDER 9 0.0002
825 HAEMATOMA 5 0.0002
826 ACUTE MYELOID LEUKAEMIA 3 0.0002
827 ARTHRALGIA 80 0.0002
828 DEAFNESS 5 0.0002
829 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
830 NEUROPATHY PERIPHERAL 18 0.0002
831 RASH ERYTHEMATOUS 9 0.0002
832 DEHYDRATION 25 0.0002
833 NIGHT SWEATS 6 0.0002
834 DYSARTHRIA 7 0.0002
835 FEAR 5 0.0002
836 INTESTINAL OBSTRUCTION 7 0.0002
837 BURNING SENSATION 13 0.0002
838 LACTIC ACIDOSIS 6 0.0002
839 ANAEMIA 35 0.0002
840 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
841 DRUG LEVEL INCREASED 3 0.0002
842 ABNORMAL DREAMS 5 0.0002
843 ANGIOEDEMA 8 0.0002
844 CYTOMEGALOVIRUS INFECTION 3 0.0002
845 MEDICATION ERROR 10 0.0002
846 FEELING COLD 5 0.0002
847 PULMONARY EMBOLISM 17 0.0002
848 WOUND 5 0.0002
849 PERICARDITIS 3 0.0002
850 RASH PAPULAR 4 0.0002
851 UNDERDOSE 13 0.0002
852 ARTHRITIS 14 0.0002
853 HEART RATE IRREGULAR 4 0.0002
854 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
855 ATRIAL FIBRILLATION 17 0.0002
856 SKIN DISCOLOURATION 8 0.0002
857 THROMBOSIS 14 0.0002
858 ORTHOSTATIC HYPOTENSION 3 0.0002
859 ECZEMA 9 0.0002
860 SPEECH DISORDER 9 0.0002
861 DYSSTASIA 5 0.0002
862 PRODUCT DOSE OMISSION ISSUE 50 0.0002
863 LYMPHADENOPATHY 6 0.0002
864 CEREBRAL HAEMORRHAGE 6 0.0002
865 PELVIC PAIN 3 0.0002
866 STOMATITIS 10 0.0002
867 HAEMATOCHEZIA 9 0.0002
868 BRONCHITIS 12 0.0002
869 BALANCE DISORDER 14 0.0002
870 CONJUNCTIVITIS 3 0.0002
871 VISUAL IMPAIRMENT 20 0.0002
872 BONE DENSITY DECREASED 5 0.0002
873 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
874 INTENTIONAL OVERDOSE 10 0.0002
875 DIPLOPIA 4 0.0002
876 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
877 RESPIRATORY TRACT INFECTION 4 0.0002
878 PARAESTHESIA 24 0.0002
879 HAEMATOCRIT DECREASED 3 0.0002
880 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
881 IRRITABILITY 9 0.0001
882 GAIT INABILITY 5 0.0001
883 DEPRESSION 34 0.0001
884 MENSTRUATION IRREGULAR 4 0.0001
885 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
886 DISEASE RECURRENCE 7 0.0001
887 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
888 HAEMOGLOBIN DECREASED 15 0.0001
889 PERITONITIS 3 0.0001
890 CHRONIC KIDNEY DISEASE 11 0.0001
891 INTENTIONAL DRUG MISUSE 3 0.0001
892 HEART RATE DECREASED 5 0.0001
893 SLEEP DISORDER 10 0.0001
894 MUSCLE SPASMS 26 0.0001
895 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
896 PRURITUS 54 0.0001
897 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
898 CONVULSION 8 0.0001
899 MOBILITY DECREASED 10 0.0001
900 MEMORY IMPAIRMENT 19 0.0001
901 INJECTION SITE HAEMORRHAGE 11 0.0001
902 CARDIAC FAILURE CONGESTIVE 11 0.0001
903 HOSPITALISATION 21 0.0001
904 LABORATORY TEST ABNORMAL 4 0.0001
905 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
906 THROAT IRRITATION 6 0.0001
907 INJECTION SITE PAIN 41 0.0001
908 APHASIA 4 0.0001
909 VERTIGO 8 0.0001
910 SKIN IRRITATION 6 0.0001
911 SKIN EXFOLIATION 11 0.0001
912 INJECTION SITE RASH 4 0.0001
913 RENAL FAILURE 17 0.0001
914 SINUSITIS 13 0.0001
915 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
916 INJECTION SITE BRUISING 10 0.0001
917 BLOOD GLUCOSE DECREASED 6 0.0001
918 HIP FRACTURE 4 0.0001
919 VISION BLURRED 17 0.0001
920 DRY MOUTH 10 0.0001
921 SWELLING FACE 8 0.0001
922 LUNG NEOPLASM MALIGNANT 5 0.0001
923 DYSGEUSIA 9 0.0001
924 HOT FLUSH 9 0.0001
925 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
926 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
927 DIABETES MELLITUS 9 0.0001
928 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
929 INJECTION SITE SWELLING 9 0.0001
930 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
931 DYSPHAGIA 11 0.0001
932 THERAPEUTIC RESPONSE DECREASED 7 0.0001
933 NEOPLASM PROGRESSION 4 0.0001
934 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
935 INJECTION SITE ERYTHEMA 14 0.0001
936 DISTURBANCE IN ATTENTION 6 0.0001
937 FREQUENT BOWEL MOVEMENTS 3 0.0001
938 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
939 RASH PRURITIC 6 0.0001
940 PRODUCT QUALITY ISSUE 15 0.0001
941 MOOD ALTERED 3 0.0001
942 HYPERGLYCAEMIA 4 0.0001
943 OROPHARYNGEAL PAIN 10 0.0001
944 DEATH 93 0.0001
945 DEEP VEIN THROMBOSIS 7 0.0001
946 EYE SWELLING 4 0.0001
947 BLISTER 6 0.0001
948 INJECTION SITE PRURITUS 7 0.0001
949 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
950 INTERSTITIAL LUNG DISEASE 5 0.0001
951 HEPATIC ENZYME INCREASED 7 0.0001
952 DYSPHONIA 6 0.0001
953 ACUTE MYOCARDIAL INFARCTION 3 0.0001
954 DISEASE PROGRESSION 12 0.0001
955 WHEEZING 6 0.0001
956 JOINT SWELLING 12 0.0001
957 GAIT DISTURBANCE 19 0.0001
958 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
959 DISCOMFORT 6 0.0001
960 ADVERSE EVENT 9 0.0001
961 HYPOTHYROIDISM 3 0.0001
962 UNEVALUABLE EVENT 7 0.0001
963 IMPAIRED HEALING 3 0.0001
964 MUSCULOSKELETAL STIFFNESS 8 0.0001
965 INFUSION RELATED REACTION 6 0.0001
966 EYE PRURITUS 3 0.0001
967 EYE PAIN 5 0.0001
968 CEREBROVASCULAR ACCIDENT 15 0.0001
969 INJECTION SITE REACTION 6 0.0001
970 BLOOD CHOLESTEROL INCREASED 4 0.0001
971 OCULAR HYPERAEMIA 4 0.0001
972 THROMBOCYTOPENIA 9 0.0001
973 BLOOD GLUCOSE INCREASED 15 0.0001
974 COLITIS 3 0.0001
975 INFLAMMATION 4 0.0001
976 BREAST CANCER 7 0.0001
977 NEOPLASM MALIGNANT 5 0.0001
978 NEUTROPENIA 10 0.0001
979 DEPENDENCE 4 0.0001
980 MENTAL DISORDER 3 0.0001
981 DRY SKIN 9 0.0001
982 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
983 MULTIPLE SCLEROSIS 3 0.0001
984 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
985 MUSCULOSKELETAL PAIN 3 0.0001
986 ADVERSE DRUG REACTION 5 0.0001
987 ACNE 4 0.0001
988 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
989 ILL-DEFINED DISORDER 3 0.0000
990 ALOPECIA 9 0.0000
991 RHEUMATOID ARTHRITIS 4 0.0000
992 MYOCARDIAL INFARCTION 6 0.0000
993 ASTHMA 3 0.0000
994 EMOTIONAL DISTRESS 3 0.0000
995 NO ADVERSE EVENT 3 0.0000